Clinical Trial Update: Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing SUBA-itraconazole to itraconazole for endemic mycoses in invasive fungal infections has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endemic Mycoses
• Invasive Fungal Infections

Drugs mentioned

• Itraconazole (Itraconazole)
• SUBA-Itraconazole (itraconazole)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Invasive Fungal Infections | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-10-06